---
title: "$Novo Nordisk AS(NVO.US) is expected to see revenue drop by 5%-13% in 2026.Taking the midpoint betwe"
description: "$Novo Nordisk AS(NVO.US) is expected to see revenue drop by 5%-13% in 2026.Taking the midpoint between the recent month's high of 64 and low of 44, around 59, for a simple calculation: 59x0.95≈56, 59x"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/38561319.md"
published_at: "2026-02-06T13:57:48.000Z"
author: "[索螺丝](https://longbridge.com/en/profiles/14196521)"
---

# $Novo Nordisk AS(NVO.US) is expected to see revenue drop by 5%-13% in 2026.Taking the midpoint betwe

$Novo Nordisk AS(NVO.US) is expected to see revenue drop by 5%-13% in 2026.

Taking the midpoint between the recent month's high of 64 and low of 44, around 59, for a simple calculation: 59x0.95≈56, 59x0.87≈51.

So, ignoring other factors, Novo Nordisk's stock price is relatively reasonable between 51-56. Of course, this hasn't yet accounted for the impact of the interest rate cut cycle.

Therefore, I estimate that the real price of Novo Nordisk is within the 51-80 range, which is normal.

Below 50 is undervalued.

51 to 60 is normal.

61 to 70 is a slight bubble.

71 to 80 is a moderate bubble.

Above 81 is a severe bubble.

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.